Introduction
In this special, joint-faculty episode, The PVD Channel is pleased to welcome back our Chair, Dr. Paul Gagne, who will be joined by Julie Berumen, RN, MSN, CCRN for an exploration of critical limb ischemia, and how to determine whether you have the right surgeon or vascular interventionalist and multidisciplinary team to optimally treat and manage your patients.
Join our experts as they review disease risk factors, and discuss optimal strategies for the multidisciplinary management of patients with peripheral arterial disease and critical limb ischemia that can help improve patient outcomes and help prevent amputations that may be unnecessary.
Learning Objectives
Upon viewing this educational episode, vascular professionals will be better able to:
- Identify the risk factors of peripheral arterial disease and critical limb ischemia
- Describe a multidisciplinary care model that coordinates wound management to provide focus on limb salvage
- Discuss the importance of regular follow-up visits and recommended appointments over a year to improve healing outcomes
Target Audience
The educational design of this activity addresses the needs of Interventional Radiologists, Vascular Surgeons, Vascular Specialists, Nurse Practitioners, Radiologic Technologists, and Vascular Allied Health Professionals involved in the treatment of patients with peripheral vascular disease.
Paul J. Gagne, MD, FACS, RVT — Chairman
Vascular Surgeon
Associate Clinical Professor of Surgery
NYU School of Medicine, New York
Private Practice, Darien, CT, USA
Dr. Paul J. Gagne is a board-certified vascular surgeon.
Dr. Gagne attended the NYU School of Medicine, and did his residency in General Surgery at NYU Medical Center. After residency, he served as a vascular surgeon in the US Navy and did a vascular fellowship at the University of Arkansas for Medical Sciences. Dr. Gagne was on faculty at NYU School of Medicine for 8 years before entering private practice in Darien, CT. Dr. Gagne is a Distinguished Member of the Society of Vascular Surgery, a member of the American Venous Forum and serves on the Board of Directors of OEIS.
On March 26, 2013, Dr. Gagne became the first surgeon in the State of Connecticut to implant a drug-eluting stent to reopen a blocked artery in the thigh of a patient with peripheral arterial disease.
Dr. Gagne is also an international leader in the treatment of acute DVT and chronic deep vein occlusive disease in the leg and the long-term complications of DVT.
Dr. Gagne’s research focuses on the deep vein system 1) following acute DVT, and 2) the use of IVUS for evaluating and treating chronic iliofemoral vein outflow obstruction. He was the Global Principal Investigator of the VIDIO trial and has completed or is currently the site Principal Investigator for the VIVO, VIRTUS, ACCESS, VERNACULAR, ABRE, VIVID, VICARES and Varithena trials, focused on all aspects of venous disease. He has also been a sub-investigator for the RANGER, REVEAL and Phoenix trials for the treatment of leg peripheral arterial disease. Dr. Gagne is an invited guest speaker at meetings all over the world to present his work on the treatment of deep vein disease.
Julie J. Berumen, RN, MSN, CCRN
Critical Limb Ischemia Navigator
Hospitals of Providence at Memorial
El Paso, TX, USA
Julie J. Berumen is a Critical Care Registered Nurse and is the Critical Limb Ischemia Navigator at the Hospitals of Providence at Memorial in El Paso, Texas. In her role, she is responsible for the care coordination of patients with peripheral artery disease, working with a multidisciplinary team of health care providers. She is also in charge of organizing staff and patient education, along with quality care improvement and risk management.
Julie earned her Bachelor of Science in Nursing from the University of Texas in El Paso and completed her Master of Science in Nursing with an emphasis in Quality and Risk Management in Phoenix, Arizona.
She has given presentations on permanent pacemakers, the risk of elevated A1Cs in relation to Peripheral Artery Disease, and 12-lead EKGs. She is a member of The American Association of Critical Care Nurses, The American Nursing Association and Texas Nursing Association, National Association for Healthcare Quality, and CLI Global Society, as well as a past president of the Paso del Norte Chapter of The American Association of Critical Care Nurses.
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Educational Awareness Solutions. Global is accredited by the ACCME to provide continuing medical education for physicians.
Physician Credit Designation
Global Education Group designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC Recognition Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 medical knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Nurse Practitioner Continuing Education
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of Global Education Group and Educational Awareness Solutions. Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 110121. This activity is approved for 0.75 contact hours (which includes 0.0 hour(s) of pharmacology).
American Society of Radiologic Technologists
This activity has been reviewed and approved for 0.75 Category A CE credits by the ASRT.
Global Contact Information
For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.
Instructions to Receive Credit
In order to receive credit for this activity, the participant must complete the pre-activity questions, view the program in its entirety, pass the post-activity questions with 75% or better and complete the evaluation form and credit request.
Fee Information and Refund/Cancellation Policy
There is no fee for this educational activity.
Disclosure of Relevant Financial Relationships
Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.
All relevant financial relationships have been mitigated.
The faculty have the following relevant financial relationships with ineligible companies:
|
Paul J. Gagne, MD, FACS, RVT
|
Consulting Fees: Philips, Cook Medical, Boston Scientific, Medtronic, Endologix
Contracted Research: Medtronic, Mercator, Reva Medical, MedAlliance, Boston Scientific, Philips, Intervene, Vesper Medical |
| Julie J. Berumen, RN, MSN, CCRN | Nothing to disclose |
The planners and managers have the following relevant financial relationships with ineligible companies:
Contracted Research: Medtronic, Mercator, Reva Medical, MedAlliance, Boston Scientific, Philips, Intervene, Vesper Medical
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Educational Awareness Solutions do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
System Requirements
An Internet-connected web browser is required.
This activity is jointly provided by Global Education Group and Educational Awareness Solutions.
This activity is supported by an educational grant from Philips Image Guided Therapy.
